Niagen Bioscience Inc. (OCD1)
Market Closed
14 Aug, 20:00
XSTU 
€
2. 58
-0.04
-1.5267%
€
- Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
-0.01 Eps
€ 2.62
Previous Close Want to track OCD1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.02 | - |
| | | 0.02 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
OCD1 Earnings Reports FAQ
What is the earnings per share (EPS) for OCD1?
The current EPS is -0.01.
What is the company's earnings growth rate?
Niagen Bioscience Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Niagen Bioscience Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Niagen Bioscience Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for OCD1 at this time, as Niagen Bioscience Inc has no recent EPS data to calculate it.
